OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Roles of p53, NF-κB and the androgen receptor in controlling NGAL expression in prostate cancer cell lines
William H. Chappell, Saverio Candido, Stephen L. Abrams, et al.
Advances in Biological Regulation (2018) Vol. 69, pp. 43-62
Closed Access | Times Cited: 21

Showing 21 citing articles:

Iron in the Tumor Microenvironment—Connecting the Dots
Christa Pfeifhofer-Obermair, Piotr Tymoszuk, Verena Petzer, et al.
Frontiers in Oncology (2018) Vol. 8
Open Access | Times Cited: 124

Deregulated PTEN/PI3K/AKT/mTOR signaling in prostate cancer: Still a potential druggable target?
Luca Braglia, Manuela Zavatti, Marco Vinceti, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Cell Research (2020) Vol. 1867, Iss. 9, pp. 118731-118731
Open Access | Times Cited: 81

Exosome-derived miR-27a produced by PSC-27 cells contributes to prostate cancer chemoresistance through p53
Zhigang Cao, Li Xu, Shuli Zhao
Biochemical and Biophysical Research Communications (2019) Vol. 515, Iss. 2, pp. 345-351
Closed Access | Times Cited: 49

NGAL as a Potential Target in Tumor Microenvironment
Elvira Crescenzi, Antonio Leonardi, Francesco Pacifico
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 22, pp. 12333-12333
Open Access | Times Cited: 28

Introduction of WT-TP53 into pancreatic cancer cells alters sensitivity to chemotherapeutic drugs, targeted therapeutics and nutraceuticals
Stephen L. Abrams, Kvin Lertpiriyapong, Li V. Yang, et al.
Advances in Biological Regulation (2018) Vol. 69, pp. 16-34
Closed Access | Times Cited: 35

TNF-α controls Lipocalin-2 expression in PC-3 prostate cancer cells
Sarah K. Schröder, Anastasia Asimakopoulou, Stefan Tillmann, et al.
Cytokine (2020) Vol. 135, pp. 155214-155214
Closed Access | Times Cited: 29

The Integration of Metabolomics with Other Omics: Insights into Understanding Prostate Cancer
Eleazer P. Resurreccion, Ka-wing Fong
Metabolites (2022) Vol. 12, Iss. 6, pp. 488-488
Open Access | Times Cited: 17

Cardamonin Induces Cell Cycle Arrest, Apoptosis and Alters Apoptosis Associated Gene Expression in WEHI-3 Mouse Leukemia Cells
Nien-Chieh Liao, Yung-Luen Shih, Jiann-Shang Chou, et al.
The American Journal of Chinese Medicine (2019) Vol. 47, Iss. 03, pp. 635-656
Closed Access | Times Cited: 26

Lipocalin-2 (LCN2) Deficiency Leads to Cellular Changes in Highly Metastatic Human Prostate Cancer Cell Line PC-3
Sarah K. Schröder, Manuela Pinoé-Schmidt, Ralf Weiskirchen
Cells (2022) Vol. 11, Iss. 2, pp. 260-260
Open Access | Times Cited: 14

Influences of TP53 and the anti-aging DDR1 receptor in controlling Raf/MEK/ERK and PI3K/Akt expression and chemotherapeutic drug sensitivity in prostate cancer cell lines
William H. Chappell, Saverio Candido, Stephen L. Abrams, et al.
Aging (2020) Vol. 12, Iss. 11, pp. 10194-10210
Open Access | Times Cited: 23

Thromboinflammatory Processes at the Nexus of Metabolic Dysfunction and Prostate Cancer: The Emerging Role of Periprostatic Adipose Tissue
Ibrahim AlZaim, Aya Al-Saidi, Safaa H. Hammoud, et al.
Cancers (2022) Vol. 14, Iss. 7, pp. 1679-1679
Open Access | Times Cited: 12

PIK3CG Is a Potential Therapeutic Target in Androgen Receptor–Indifferent Metastatic Prostate Cancer
Wen-Cheng Chung, Xinchun Zhou, Azeddine Atfi, et al.
American Journal Of Pathology (2020) Vol. 190, Iss. 11, pp. 2194-2202
Open Access | Times Cited: 18

The Metabolism Symbiosis Between Pancreatic Cancer and Tumor Microenvironment
Ying Li, Ju Zhang, Jie Xu, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 12

The Differential Antitumor Activity of 5-Aza-2'-deoxycytidine in Prostate Cancer DU145, 22RV1, and LNCaP Cells
Huiying Cheng, Sijie Tang, Xueqi Lian, et al.
Journal of Cancer (2021) Vol. 12, Iss. 18, pp. 5593-5604
Open Access | Times Cited: 10

Abilities of β-Estradiol to interact with chemotherapeutic drugs, signal transduction inhibitors and nutraceuticals and alter the proliferation of pancreatic cancer cells
Shaw M. Akula, Saverio Candido, Stephen L. Abrams, et al.
Advances in Biological Regulation (2019) Vol. 75, pp. 100672-100672
Closed Access | Times Cited: 10

Hybrid panel of biomarkers can be useful in the diagnosis of pleural and peritoneal effusions
Daniel K. Faria, Caroline Silvério Faria, Dimitria Doi, et al.
Clinica Chimica Acta (2019) Vol. 497, pp. 48-53
Open Access | Times Cited: 9

Sensitivity of pancreatic cancer cells to chemotherapeutic drugs, signal transduction inhibitors and nutraceuticals can be regulated by WT-TP53
Stephen L. Abrams, Shaw M. Akula, Alberto M. Martelli, et al.
Advances in Biological Regulation (2021) Vol. 79, pp. 100780-100780
Closed Access | Times Cited: 7

Combination of neutrophil gelatinase-associated lipocalin and matrix metalloproteinase-9 are biomarkers for the detection of colon tubular adenocarcinoma
Jun-Hua Yuan, Li-Shuang Xie, Zhu Yu-hua, et al.
World Journal of Gastrointestinal Oncology (2021) Vol. 13, Iss. 10, pp. 1506-1517
Open Access | Times Cited: 1

Emphasizing the Role of Multi-omics Approach to Increase Survival Rate of Breast and Prostate Cancer Patients
Khushali Upadhyay, Foram Patel, Y. Patel, et al.
Journal of Endocrinology & Reproduction (2023), pp. 147-155
Open Access

Page 1

Scroll to top